ALBANY MOLECULAR RESEARCH INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALBANY MOLECULAR RESEARCH INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | M | 12.85 | 5,000 | 64,250 | 0 | |
| Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Sell | S | 15.95 | 5,000 | 79,750 | 36,856 | 41.9 K to 36.9 K (-11.95 %) |
| Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Buy | M | 12.85 | 5,000 | 64,250 | 41,856 | 36.9 K to 41.9 K (+13.57 %) |
| Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | M | 12.85 | 5,000 | 64,250 | 0 | |
| Feb 28 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Buy | M | 12.85 | 5,000 | 64,250 | 40,210 | 35.2 K to 40.2 K (+14.20 %) |
| Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | M | 2.93 | 2,500 | 7,325 | 25,000 | |
| Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 15.19 | 2,500 | 37,975 | 34,838 | 37.3 K to 34.8 K (-6.70 %) |
| Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Buy | M | 2.93 | 2,500 | 7,325 | 37,338 | 34.8 K to 37.3 K (+7.18 %) |
| Feb 27 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | M | 9.34 | 3,000 | 28,020 | 0 | |
| Feb 27 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 15.73 | 3,000 | 47,190 | 34,838 | 37.8 K to 34.8 K (-7.93 %) |
| Feb 27 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Buy | M | 9.34 | 3,000 | 28,020 | 37,838 | 34.8 K to 37.8 K (+8.61 %) |
| Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | VP, CFO and Treasur ... | Option Exercise | M | 3.43 | 15,000 | 51,450 | 85,000 | |
| Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | VP, CFO and Treasur ... | Sell | S | 15.00 | 15,000 | 225,000 | 76,093 | 91.1 K to 76.1 K (-16.47 %) |
| Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | VP, CFO and Treasur ... | Buy | M | 3.43 | 15,000 | 51,450 | 91,093 | 76.1 K to 91.1 K (+19.71 %) |
| Feb 24 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 14.87 | 1,500 | 22,305 | 34,838 | 36.3 K to 34.8 K (-4.13 %) |
| Feb 19 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | VP, Secretary & Gen ... | Payment of Exercise | F | 0.00 | 1,038 | 0 | 58,997 | 60 K to 59 K (-1.73 %) |
| Feb 19 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 13.37 | 1,500 | 20,055 | 36,338 | 37.8 K to 36.3 K (-3.96 %) |
| Feb 19 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 1,038 | 0 | 37,838 | 38.9 K to 37.8 K (-2.67 %) |
| Feb 14 2014 | AMRI | ALBANY MOLECULAR R ... | CABLE STUART M | 10% Owner | Sell | S | 12.00 | 30,000 | 360,000 | 4,353,289 | 4.4 M to 4.4 M (-0.68 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Sr. VP Sales & GM o ... | Option Exercise | A | 10.43 | 29,167 | 304,212 | 29,167 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Svokos George | Sr. VP Sales & GM o ... | Grant | A | 10.43 | 14,584 | 152,111 | 44,584 | 30 K to 44.6 K (+48.61 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Luther Michael A | Senior VP, Discover ... | Option Exercise | A | 10.43 | 25,000 | 260,750 | 25,000 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Luther Michael A | Senior VP, Discover ... | Grant | A | 10.43 | 12,500 | 130,375 | 32,500 | 20 K to 32.5 K (+62.50 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | VP, Secretary & Gen ... | Option Exercise | A | 10.43 | 29,167 | 304,212 | 29,167 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | VP, Secretary & Gen ... | Grant | A | 10.43 | 14,584 | 152,111 | 60,035 | 45.5 K to 60 K (+32.09 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | VP, Secretary & Gen ... | Payment of Exercise | F | 0.00 | 948 | 0 | 45,451 | 46.4 K to 45.5 K (-2.04 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | A | 10.43 | 25,000 | 260,750 | 25,000 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Grant | A | 10.43 | 12,500 | 130,375 | 38,876 | 26.4 K to 38.9 K (+47.39 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | VP, CFO and Treasur ... | Option Exercise | A | 10.43 | 33,333 | 347,663 | 33,333 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | VP, CFO and Treasur ... | Grant | A | 10.43 | 16,666 | 173,826 | 76,093 | 59.4 K to 76.1 K (+28.04 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 10.50 | 95,238 | 999,999 | 283,699 | 188.5 K to 283.7 K (+50.53 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 10.43 | 3,356 | 35,003 | 30,874 | 27.5 K to 30.9 K (+12.20 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | ROTH ARTHUR J | Director | Grant | A | 10.43 | 3,356 | 35,003 | 36,856 | 33.5 K to 36.9 K (+10.02 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | OCONNOR KEVIN | Director | Grant | A | 10.43 | 3,356 | 35,003 | 35,210 | 31.9 K to 35.2 K (+10.54 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Grant | A | 10.43 | 3,356 | 35,003 | 28,677 | 25.3 K to 28.7 K (+13.25 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Jordan Veronica GH | Director | Grant | A | 10.43 | 3,356 | 35,003 | 33,937 | 30.6 K to 33.9 K (+10.97 %) |
| Feb 04 2014 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Payment of Exercise | F | 0.00 | 1,905 | 0 | 188,461 | 190.4 K to 188.5 K (-1.00 %) |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Option Exercise | A | 10.43 | 7,201 | 75,106 | 7,201 | |
| Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | D AMBRA THOMAS E PHD | Chairman, Board of ... | Grant | A | 10.43 | 3,356 | 35,003 | 2,848,546 | 2.8 M to 2.8 M (+0.12 %) |
| Feb 04 2014 | AMRI | ALBANY MOLECULAR R ... | Nolan Michael M | VP, CFO and Treasur ... | Payment of Exercise | F | 0.00 | 1,384 | 0 | 59,427 | 60.8 K to 59.4 K (-2.28 %) |
| Feb 04 2014 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | VP, Secretary & Gen ... | Payment of Exercise | F | 0.00 | 1,106 | 0 | 46,399 | 47.5 K to 46.4 K (-2.33 %) |
| Feb 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 1,038 | 0 | 26,376 | 27.4 K to 26.4 K (-3.79 %) |